Publication: Trigeminal nerve stimulation: a recently approved treatment approach in attention deficit hyperactivity disorder
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Çöpür, Mazlum
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Attention-deficit hyperactivity disorder (ADHD) with its high prevalence is a growing area of concern and research, whereas exact underlying pathophysiology remains unknown. Behavioral therapy and multiple medications include methylphenidate, atomoxetine, and amphetamines while trigeminal nerve stimulator (TNS) is the first medical device in ADHD with FDA approval. The aim of this article is to evaluate the latest studies in this field.
Source
Publisher
Springer
Subject
Citation
item.page.haspartof
Source
Egyptian Journal of Neurology Psychiatry and Neurosurgery
item.page.ispartofseries
item.page.edition
DOI
10.1186/s41983-021-00353-w
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A